ZEB1/2-mediated transcriptional repression of E-cadherin is necessary for epithelial-to-mesenchymal transition, so the upregulation of ZEB1/2 could contribute to the invasiveness of tamoxifen-resistant breast cancer cells. This evidence concerns the gene ZEB1 and breast carcinoma.